In the last trading session, 0.16 million AEON Biopharma Inc (AMEX:AEON) shares changed hands as the company’s beta touched 0.17. With the company’s per share price at $0.58 changed hands at -$0.02 or -2.92% during last session, the market valuation stood at $23.26M. AEON’s last price was a discount, traded about -2860.34% off its 52-week high of $17.17. The share price had its 52-week low at $0.52, which suggests the last value was 10.34% up since then. When we look at AEON Biopharma Inc’s average trading volume, we note the 10-day average is 0.25 million shares, with the 3-month average coming to 200.18K.
Analysts gave the AEON Biopharma Inc (AEON) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AEON as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. AEON Biopharma Inc’s EPS for the current quarter is expected to be -0.18.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AEON Biopharma Inc (AMEX:AEON) trade information
Instantly AEON was in red as seen at the end of in last trading. With action -10.48%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -91.92%, with the 5-day performance at -10.48% in the red. However, in the 30-day time frame, AEON Biopharma Inc (AMEX:AEON) is 9.77% up. Looking at the short shares, we see there were 0.16 million shares sold at short interest cover period of 1.6 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2024 estimates are for AEON Biopharma Inc earnings to increase by 242.86%.
AEON Dividends
AEON Biopharma Inc is expected to release its next quarterly earnings report in January.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 36.23% of AEON Biopharma Inc shares while 33.14% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 51.98%.
